PHX vs TRI

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

PHX

PHARMX FPO [PHX]

42LOW

TRI

TRIVARX FPO [TRI]

51MEDIUM

Score Breakdown

PHX TRI
Technical
57
32
Catalyst
51
50
Sentiment
50
50
Fundamental
66
55
Momentum
55
67
Risk Gate
50
35

Key Metrics

PHX Metric TRI
$79.1MMarket Cap$20.8M
448KAvg Volume (20d)547K
N/AShort InterestN/A
$0.20052-Week High$0.035
$0.08452-Week Low$0.008
+0.0%Daily Change+0.0%
$0.120Reference Price$0.018
-5.9%ROE-12.1%
-12.2%Profit MarginN/A

Active Signals

PHX Signals

●Beating the Small Ords index — relative strength of 1.12, so it's outpacing the pack
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Moderate P/S ratio (10.3x)
●Small-cap ($20-100M)
●Capital raise activity (1 events)
●CANSLIM S: Tight float (41%)
●Negative profit margins (-12%)

TRI Signals

●RSI drifting toward oversold territory — worth watching
●MACD momentum is losing steam
●Stochastic is deep in oversold territory — bounce conditions forming
●Trading below both moving averages — the trend is working against this one
●Sitting near support — this level has held before and could attract buyers again
●Took a hit — down 10.0% over the last 5 days
●Lagging the Small Ords index — relative strength of 0.84, underperforming its peers
●Below the 200-day average — the long-term trend is still working against it

Ask Scout AI to compare PHX and TRI in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

PIQ vs SOM →PIQ vs SPL →PKP vs RAD →PKP vs SHG →PKY vs RCE →
PHX Full Analysis → TRI Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).